DRGX antibody (C-Term)
Quick Overview for DRGX antibody (C-Term) (ABIN1450061)
Target
See all DRGX AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human, Mouse, Rat.
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- 19 amino acid synthetic peptide near the carboxy terminus of Human DRGX
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- DRGX (Dorsal Root Ganglia Homeobox (DRGX))
-
Alternative Name
- DRGX / PRRXL1
-
Background
- DRGX, also known as DRG11 or PRRXL1, is a paired homeodomain transcription factor, and was initially cloned from a differential hybridization screen aimed at identifying dorsal root ganglia (DRG)-specific genes. DRGX is a key regulator of the differentiation of the spinal cord neuronal circuit dedicated to the processing of nociceptive information. DRGX is also important for the formation of the whisker-related somatosensory maps in the principal sensory nucleus of the trigeminal nerve, thalamus and somatosensory cortex.Synonyms: Dorsal root ganglia homeobox protein, Paired-related homeobox protein-like 1
-
Gene ID
- 644168
-
NCBI Accession
- NP_001073989
Target
-